Complementary medicine and HIV infection

Primary Care - Clinics in Office Practice

Volumn 24, Issue 4, 1997, Pages 905-919

  Elion, R A ^a   Cohen, C ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANABOLIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CURCUMIN; GLUTAMINE; GLUTATHIONE; MINERAL; NANDROLONE; OXANDROLONE; RETINOL; TESTOSTERONE; VITAMIN B COMPLEX; ZINC;

ACUPUNCTURE; ALTERNATIVE MEDICINE; CHINESE MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL; DIET SUPPLEMENTATION; HERB; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASSAGE; NUTRITION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

EID: 0031473904     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70316-X     Document Type: Article

References (57)

1. B. Akerlund Effect of N-acetylcysteine treatment on HIV-1 infection: A double-blind placebo controlled trial Eur J Clin Pharmalogical 50 1996 457 461
2. J.P. Allard Effects of antioxidant vitamin supplementation in patients with HIV infection Nutrition 13 1997 3 273
3. AMFAR CBCTN report, 1996.
4. B.R. Bates Complementary therapy use among HIV-infected patients AIDS Patient Care and STDs 1996 32 36
5. M.K. Baum Micronutrient status in relationship to mortality in HIV-1 disease Nutrition, March 1997 13 1997 3 273
6. M.K. Baum Association of B-6 states with parameters of immune function J AIDS 4 1991 1122 1132
7. R.S. Beach Specific nutrient abnormalities in asymptomatic HIV-infected patients AIDS 6 1992 701 708
8. Buhl Systemic Glutathione deficiency in symptom free HIV seropositive individuals Lancet 2 1989 1294 1298
9. J. Burack Pilot randomized controlled trials of Chinese herbal treatments for HIV-associated symptoms J AIDS 12 1996 386 393
10. R. Cathcart Is vitamin C helpful for HIV infection? Med Hypothesis 14 1984 439 433
11. C.W. Chang Differential inhibition of reverse transcriptase and cellular DNA polymerase Antivirol Res 4 1995 367 374
12. G. Beall M. Grosvenor R.T. Chlebowski Long term effects of early nutritional support and new entertropic peptide based formula and standard enteral formulas Nutrition 9 6 1993 507 512
13. G. Coodley Beta carotene in HIV infection J Acq Immun Defic Syndr 6 1993 272 276
14. T.P. Cooley L.M. Kunches C.A. Saunders Once-daily administration of 2,3,-dideoxyinosind (ddi) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: Results of a phase trial N Engl J Med 322 1990 1340 1345
15. D.D. Coward The lived experience of self-transcendence in women with AIDS J Obstet Gynecol Neonat Nurs Marl 24 1995 314 318
16. M.C. Delmas-Beauleux The enzymatic and antioxidant system in blood and glutathione status in HIV infected patients: Effects of supplemation with selenium or B-carotene Am J Clin Nutr 64 1 1996 101 107
17. Dezube B, et al: Pentoxifylline decreases tumor necrosis factor and may decrease HIV. Replication in AIDS patients (PO-B23-2142) Ninth International Conference on AIDS. Berlin, 1993, 492
18. B.M. Dworkin Selenium deficiency in HIV infections and AIDS Chem Biol Interact 2–3 1994 181 186
19. H.P. Eck H. Gmunder M. Hartmann Acid soluble thiol (cyoteine) in the blood plasma of HIV-I infected patients Biol Chem Hoppe-Seyler 370 1989 101 108
20. D.M. Eisenberg R.C. Kessler C. Foster Unconventional medicine in the United States: Prevalence, costs and patterns of use N Engl J Med 328 1993 246 252
21. M.A. Pischl The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection A double-blind, placebo-controlled trial N Engl J Med 317 1987 185 191
22. R.M. Greenblatt H. Hollander J.R. McMaster Polypharmacy among patients attending an AIDS clinic: Utilization of prescribed, unorthodox, and investigational treatments J Acquir Immune Defic Syndr 4 1991 136 143
23. R.F. Grimble Nutritional antioxidants and the modulation of inflammation—Theory & practice New Horizon 2 2 1994 175 185
24. C. Grunfeld What causes wasting in AIDS N Engl J Med 333 2 1995 123 124
25. R. Hand Alternative therapies used by patients with AIDS N Engl J Med 320 1989 672 673
26. Hasset J, et al: Effect of low-dose oral interferon alfa-N3 in ARC (PO-B28-2151) Ninth Intl Conf on AIDS, Berlin, 1993, p. 494
27. L. Herzenberg Glutathione deficiency is associated with impaired survival in HIV disease Proc Nat Acad Sci USA 94 1997 5 1967–1972
28. M.R. Hulton Randomized placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients J Acquir Immune Defic Syndr 5 1992 1084 1090
29. G. Ironson Massage therapy is associated with enhancement of the immune system's cytotoxic capacity Int J Neurosci 1996 205 217
30. Jariwalla RJ, et al: HIV suppression by ascorbate and its enhancement by glutathione precursor (POB 3697) Proceedings of the Eighth International Conference on AIDS, Amsterdam 2:B207, 1992
31. C. Junkers Dietary supplementation with fish-oil prevents the loss of lean body mass and attenuates the increase in TNF Production in AIDS Nutrition 13 1997 3 273
32. D.P. Kotler Magnitude of body-cell mass deplation and the timing of death from wasting in AIDS Am J Clin Nutr 50 1989 444 447
33. Laifer G, et al: Frequent use of alternative therapies and higher subjective benefit compared to traditional medicine in HIV-infected patients (POB 3396) Proceedings Eighth International Conference on AIDS. Amsterdam, 2:B152, 1992
34. C.G. Lyketsos Depressive symptoms over the course of HIV infection before AIDS Soc-Psych-Epidemiol 31 11 1996
35. D.C. Macallan Energy expenditure and wasting human immunodeficiencyvirus infections N Engl J Med 333 2 1995 83 88
36. J.A. McCutchan Unproven and Unconventional Therapies. Textbook of AIDS Medicine 1994 Williams and Wilkins New York 807 813
37. McKinley MJ, et al: Improved body weight status as a result of dietary intervention in adult HIV-positive outpatients. J Am Diet Assoc 94:1014–7,
38. M. Ott BIA as a predictor of survival in patients with AIDS J AIDS Hum Retrov 9 1995 20 25
39. M. Ott Intestinal Absorption and malnutrition in patients with AIDS Z Gastroenterol 31 11 1993 661 665
40. J.G. Palenicek Weight loss prior to clinical AIDS as a predictor of survival J AIDS Hum Retrov 10 3 1995 366 373
41. R. Remien L. Katoff J.G. Rabkin Suicidality in AIDS longterm survivors AIDS Care 5 4 1993 401 411
42. S. Rapa Zinc d Immune Function Minerva Med 86 7-8 1995 315 318
43. Roederer M, Positive Effects of Antioxidant Therapy in HIV disease: Immune function and survival. Presented at Cambridge Healthtech Novel HIV Therapeutic Strategies, November 21, 1996, Reston, Virginia
44. G. Shor-Posner Cobalamin status and cognitive performance in HIV disease Nutrition 13 3 1997 273
45. D.W. Spence Progressive resistance exercise: Effect on muscle function and anthropometry of a select AIDS population Arch Phys Med Rehabil 71 1990 1990 644–648
46. Suarez M, et al: Use of alternative healing practices among HIV-infected Hispanics (POD22-409). Ninth International Conference on AIDS. Berlin, 1993, p. 899
47. Suttman J, et al: Incidence and prognostic value of malnutrition and wasting in HIV infected out patients. J AIDS Hum Retrov:239–246
48. Y.J. Suzuki Inhibition of NF Kappa B action by vitamin E Dtsch Biochem Biophys Res Comm 5–20 193 1 1993 277 283
49. Tang A et al: The effect of micronutrient intakes on survival time in HIV-infected gay and bisexual men. APHA 11.94, abstract book, p. 2082, 1994
50. X. Tang Screening anti-HIV Chinese maleria with HIV and equine infectious anemic virus reverse transcriptase J Rad Chin Med 314 1 1994 10 13
51. Valentine C. et al: Anonymous questionnaire to assess consumption of prescribed and alternative medication and patterns of recreational drug use in an HIV positive population (ThB 1508) Proceedings Eighth International Conference on AIDS. Amsterdam, 2:B154, 1992
52. Y. Wang Is vitamin E supplementation useful agent in AIDS therapy? Prog Fed Nutr Sci 4 1993 351 375
53. Wheeler et al: Change in bony weight as a predictor of opportunistic complications in HIV. Abstract at the 35th International Conference on Antimicrobial Agents and Chemotherapeutics, San Francisco, 1995
54. X. Wu Apoptosis of HIV infected cells following treatment with ShoSaiko-to and its components Japan J Med Sci Biol 48 2 1995 79 87
55. Risks of Echinacea (Dan Brown, PhD, personal communication)
56. D. Abrams Dealing with Alternative Therapies for HIV M.A. Sande P.A. Voberding The Medical Management of AIDS ed 5 1997 WB Saunders Philadelphia 143 148
57. Cohen M: Benefits of acupuncture with HIV. Presented at the Omega Institute, June 1-2, 1994